Diagnosis Code: 199.1

Short Description: Malignant neoplasm NOS

Long Description: Other malignant neoplasm without specification of site

Code Classification:

• Neoplasms (140–239)
  • Malignant neoplasm of other and unspecified sites (190-199)
    • 199 Malignant neoplasm without specification of site
      • 199.1 Malignant neoplasm NOS

Code Version: 2015 ICD-9-CM

Synonyms

• Anemia in malignant neoplastic disease
• Arthritis secondary to malignancy
• Basal cell carcinoma - first recurrence
• Basal cell carcinoma - multiple recurrences
• Basal cell carcinoma - second recurrence
• Basal cell carcinoma - third recurrence
• Basal cell carcinoma with monster cells
• Basal cell carcinoma with signet ring change
• Cancer confirmed
• Eaton Lambert syndrome with underlying malignancy
• Erythema multiforme due to malignancy
• Extraprostatic extension of tumor present, focal
• Fracture of bone in neoplastic disease
• Hormone receptor positive tumor
• Human immunodeficiency virus disease resulting in multiple malignant neoplasms
• Human immunodeficiency virus with secondary cancers
• Hypermelanosis due to malignant adrenocorticotropic hormone/melanocyte stimulating hormone-secreting tumor
• Intraepithelial squamous cell carcinoma
• Invasion of neoplasm to visceral peritoneum
• Malignant adenomatous neoplasm
• Malignant carcinoid tumor
• Malignant infiltration of skin by underlying tumor
• Malignant neoplasm associated with acquired immunodeficiency syndrome
• Malignant neoplastic disease
• Malignant neoplastic disease in mother complicating childbirth
• Malignant neoplastic disease in pregnancy
• Malignant tumor involving an organ by direct extension from bladder
• Malignant tumor involving an organ by direct extension from endometrium
• Malignant tumor involving an organ by direct extension from fallopian tube
• Malignant tumor involving an organ by direct extension from ovary
• Malignant tumor involving an organ by direct extension from prostate
• Malignant tumor involving an organ by direct extension from uterine cervix
• Malignant tumor involving an organ by direct extension from uterus
• Malignant tumor involving an organ by direct extension from vagina
• Malignant tumor involving an organ by separate metastasis from bladder
• Malignant tumor involving an organ by separate metastasis from endometrium
• Malignant tumor involving an organ by separate metastasis from fallopian tube
• Malignant tumor involving an organ by separate metastasis from ovary
• Malignant tumor involving an organ by separate metastasis from prostate
• Malignant tumor involving an organ by separate metastasis from uterine cervix
• Malignant tumor involving an organ by separate metastasis from uterus
• Malignant tumor involving an organ by separate metastasis from vagina
• Malignant tumor of ill-defined site
• Malignant tumor of unknown origin
• Malignant tumor of unknown origin or ill-defined site
• Mesothelioma
• Metastasis from malignant melanoma of skin
• Metastasis from malignant tumor of adrenal gland
• Metastasis from malignant tumor of bladder
• Metastasis from malignant tumor of bone
• Metastasis from malignant tumor of breast
• Metastasis from malignant tumor of bronchus
• Metastasis from malignant tumor of buccal cavity
• Metastasis from malignant tumor of cervix
• Metastasis from malignant tumor of colon
• Metastasis from malignant tumor of esophagus
• Metastasis from malignant tumor of gallbladder
• Metastasis from malignant tumor of kidney
• Metastasis from malignant tumor of liver
• Metastasis from malignant tumor of lung
• Metastasis from malignant tumor of pancreas
• Metastasis from malignant tumor of prostate
• Metastasis from malignant tumor of rectum
• Metastasis from malignant tumor of skin
• Metastasis from malignant tumor of soft tissues
• Metastasis from malignant tumor of stomach
• Metastasis from malignant tumor of thyroid
• Metastasis from malignant tumor of tongue
• Metastasis from malignant tumor of uterus
• Metastasis to adrenal gland of unknown primary
• Metastasis to bladder of unknown primary
• Metastasis to bone of unknown primary
• Metastasis to brain of unknown primary
• Metastasis to breast of unknown primary
• Metastasis to bronchus of unknown primary
• Metastasis to colon of unknown primary
• Metastasis to eye of unknown primary
• Metastasis to heart of unknown primary
• Metastasis to kidney of unknown primary
• Metastasis to large intestine of unknown primary
• Metastasis to liver from adenocarcinoma
• Metastasis to liver of unknown primary
• Metastasis to lung from adenocarcinoma
• Metastasis to lung of unknown primary
• Metastasis to lymph node from squamous cell carcinoma
• Metastasis to lymph node of unknown primary
• Metastasis to mediastinum of unknown primary
• Metastasis to multiple lymph nodes
• Metastasis to ovary of unknown primary
• Metastasis to pancreas of unknown primary
• Metastasis to peritoneum of unknown primary
• Metastasis to pleura of unknown primary
• Metastasis to rectum of unknown primary
• Metastasis to retroperitoneum of unknown primary
• Metastasis to skin of unknown primary
• Metastasis to small intestine of unknown primary
• Metastasis to soft tissue of unknown primary
• Metastasis to spleen of unknown primary
• Metastasis to thymus of unknown primary
• Metastasis to trachea of unknown primary
• Metastasis to uterus of unknown primary
• Metastasis to vagina of unknown primary
• Metastasis to vertebral column of unknown primary
• Metastatic adenocarcinoma of unknown origin
• Metastatic basal cell carcinoma
• Metastatic malignant neoplasm to apex of urinary bladder
• Metastatic malignant neoplasm to dome of urinary bladder
• Metastatic malignant neoplasm to lateral axillary lymph nodes
• Metastatic malignant neoplasm to nasopharynx
• Metastatic renal cell carcinoma
• Metastatic squamous cell carcinoma
• Mucinous adenocarcinoma cells present, comprising less than 50% of malignant cells
• Oxyphilic adenocarcinoma
• Pain from metastases
• Panniculitis secondary to malignancy
• Paraneoplastic peripheral neuropathy
• Paraneoplastic sensorimotor neuropathy
• Paraneoplastic sensory neuropathy
• Pericarditis secondary to malignant primary tumor
• Pleuropulmonary blastoma family tumor susceptibility syndrome
• Polymyositis with malignant disease
• Primary malignant neoplasm
• Primary malignant neoplasm of unknown site
• Renal involvement in malignant disease
• Secondary malignant neoplasm of submaxillary gland
• Secondary malignant neoplastic disease
• Signet ring squamous cell carcinoma
• Signet-ring cells present, comprising less that 50% of malignant cells
• Spindle cell squamous cell carcinoma
• Squamous cell carcinoma arising in chronic ulcer
• Surgical deep margin is closest uninvolved margin to ductal carcinoma in situ
• Surgical deep margin is closest uninvolved margin to malignant neoplasm
• Surgical lateral margin is closest uninvolved margin to ductal carcinoma in situ
• Surgical medial margin involved by malignant neoplasm
• Surgical medial margin is closest uninvolved margin to ductal carcinoma in situ
• Surgical superior margin involved by malignant neoplasm
• Thrombophilia due to malignant neoplasm
• Trichilemmal carcinoma
• Verrucous squamous cell carcinoma
• Widespread metastatic malignant neoplastic disease

References to Index of Diseases and Injuries

The code 199.1 has the following ICD-9-CM references to the Index of Diseases and Injuries

• Myasthenia 358.00
  • syndrome
    • in
      • malignant neoplasm NEC 199.1 [358.1]

• Myopathy 359.9
  • in
    • malignant neoplasm NEC (M8000/3) 199.1 [359.6]

• Neoplasm, neoplastic������������������������������� 199.1��� 199.1����� 234.9����� 229.9����� 238.9����� 239.9

•  
  • metastatic NEC�see also Neoplasm, by site, secondary����������������������� � -������� 199.1����� -������������ -������������ -������������ -
  • unknown site or unspecified���������������� 199.1��� 199.1����� 234.9����� 229.9����� 238.9����� 239.9

• Polyneuropathy (peripheral) 356.9
  • in
    • malignant neoplasm (M8000/3) NEC 199.1 [357.3]

Crosswalk Information

The code 199.1 converts into the following ICD-10 code(s):

Similar Codes

This page was last updated on: 10/1/2014

« Previous Code